These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33718113)

  • 1. The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy.
    Shriwas O; Mohapatra P; Mohanty S; Dash R
    Front Oncol; 2020; 10():612337. PubMed ID: 33718113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.
    Song N; Cui K; Zhang K; Yang J; Liu J; Miao Z; Zhao F; Meng H; Chen L; Chen C; Li Y; Shao M; Zhang J; Wang H
    Front Pharmacol; 2022; 13():933332. PubMed ID: 35784761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.
    Qu L; Liu SJ; Zhang L; Liu JF; Zhou YJ; Zeng PH; Jing QC; Yin WJ
    Cancer Control; 2024; 31():10732748241247170. PubMed ID: 38662732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Critical Role of RNA m
    Lan Q; Liu PY; Haase J; Bell JL; Hüttelmaier S; Liu T
    Cancer Res; 2019 Apr; 79(7):1285-1292. PubMed ID: 30894375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of m6A RNA methylation in cancer.
    Sun T; Wu R; Ming L
    Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of m6A RNA methylation in cardiovascular disease (Review).
    Qin Y; Li L; Luo E; Hou J; Yan G; Wang D; Qiao Y; Tang C
    Int J Mol Med; 2020 Dec; 46(6):1958-1972. PubMed ID: 33125109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
    Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R
    Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
    Yu L; Gao Y; Bao Q; Xu M; Lu J; Du W
    Heliyon; 2024 Jan; 10(2):e24414. PubMed ID: 38293446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Roles of RNA m
    Lan Q; Liu PY; Bell JL; Wang JY; Hüttelmaier S; Zhang XD; Zhang L; Liu T
    Cancer Res; 2021 Jul; 81(13):3431-3440. PubMed ID: 34228629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.
    Mu X; Zhao Q; Chen W; Zhao Y; Yan Q; Peng R; Zhu J; Yang C; Lan K; Gu X; Wang Y
    Front Oncol; 2020; 10():526866. PubMed ID: 33489865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
    Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
    Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis.
    Fu J; Cui X; Zhang X; Cheng M; Li X; Guo Z; Cui X
    Front Genet; 2021; 12():733871. PubMed ID: 34603394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YTHDF1 Negatively Regulates
    Li Z; Teng M; Jiang Y; Zhang L; Luo X; Liao Y; Yang B
    Front Immunol; 2022; 13():857727. PubMed ID: 35444649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of m6A RNA modification in cancer therapeutic resistance.
    Liu WW; Zhang ZY; Wang F; Wang H
    Exp Hematol Oncol; 2023 Feb; 12(1):21. PubMed ID: 36810281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.